Puma Biotechnology Inc (PBYI)

NASDAQ
1.940
+0.030(+1.57%)
  • Volume:
    10,823
  • Day's Range:
    1.905 - 1.950
  • 52 wk Range:
    1.600 - 11.950

PBYI Overview

Prev. Close
1.91
Day's Range
1.905-1.95
Revenue
200.72M
Open
1.92
52 wk Range
1.6-11.95
EPS
-1.2
Volume
10,823
Market Cap
86.35M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
446,816
P/E Ratio
-
Beta
1.09
1-Year Change
-80.67%
Shares Outstanding
44,973,141
Next Earnings Date
Aug 11, 2022
What is your sentiment on Puma Biotech?
or
Vote to see community's results!

Puma Biotechnology Inc News

Puma Biotechnology Inc Analysis

Puma Biotechnology Inc Company Profile

Puma Biotechnology Inc Company Profile

Employees
196

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company’s drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong BuyStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellStrong Sell
  • Just look at this stpd chart. How crazy rich are these Puma Sellers. They only laugh at poor Puma
    0
    • Pump* Biotech
      0
      • What’s going on with this toxic stock
        0
        • Puma Biotechnology Q1 Adj. EPS $(0.200) Beats $(0.730) Estimate, Sales $48.600M Beat $47.060M Estimate
          0
          • 14,5 short
            0
            • today will be earnings as All eyes will be on the Useless CEO
              0
              • Leerink set PT to $115. Wonder if they think there is no immediate buyer?
                0
                • $PBYI will be presenting at ASCO on 6/3/17. Buy the stock now... This can go above $100 easily before the event
                  1